Adina Aviram

496 total citations
20 papers, 397 citations indexed

About

Adina Aviram is a scholar working on Molecular Biology, Hematology and Genetics. According to data from OpenAlex, Adina Aviram has authored 20 papers receiving a total of 397 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Molecular Biology, 9 papers in Hematology and 5 papers in Genetics. Recurrent topics in Adina Aviram's work include Acute Myeloid Leukemia Research (5 papers), Chronic Myeloid Leukemia Treatments (5 papers) and Chronic Lymphocytic Leukemia Research (4 papers). Adina Aviram is often cited by papers focused on Acute Myeloid Leukemia Research (5 papers), Chronic Myeloid Leukemia Treatments (5 papers) and Chronic Lymphocytic Leukemia Research (4 papers). Adina Aviram collaborates with scholars based in Israel, Taiwan and Poland. Adina Aviram's co-authors include Ada Rephaeli, Abraham Nudelman, Meora Feinmesser, Emmilia Hodak, Michael David, Ella Kaganovsky, Mati Shaklai, Matityahu Shaklai, Irit Aviram and Esther Rabizadeh and has published in prestigious journals such as Blood, FEBS Letters and Journal of Medicinal Chemistry.

In The Last Decade

Adina Aviram

18 papers receiving 391 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Adina Aviram Israel 11 206 94 71 68 62 20 397
R P Warrell United States 9 484 2.3× 40 0.4× 267 3.8× 63 0.9× 12 0.2× 14 557
Denise Levitan United States 8 331 1.6× 22 0.2× 229 3.2× 86 1.3× 21 0.3× 18 546
Sara Morrow United States 6 216 1.0× 77 0.8× 59 0.8× 243 3.6× 17 0.3× 13 522
Zhifang Zhai China 14 97 0.5× 91 1.0× 12 0.2× 60 0.9× 24 0.4× 34 414
C. Norman Coleman United States 5 140 0.7× 21 0.2× 20 0.3× 125 1.8× 14 0.2× 7 295
Scott J. Ragg Australia 10 139 0.7× 22 0.2× 65 0.9× 75 1.1× 15 0.2× 20 462
Chaitanya Iragavarapu United States 8 213 1.0× 9 0.1× 62 0.9× 138 2.0× 21 0.3× 15 392
Inês Mota Portugal 11 125 0.6× 49 0.5× 91 1.3× 117 1.7× 16 0.3× 21 382
Shihong Shao China 12 86 0.4× 10 0.1× 68 1.0× 69 1.0× 22 0.4× 27 368
Renee Neades United States 11 249 1.2× 27 0.3× 134 1.9× 63 0.9× 13 0.2× 14 456

Countries citing papers authored by Adina Aviram

Since Specialization
Citations

This map shows the geographic impact of Adina Aviram's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Adina Aviram with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Adina Aviram more than expected).

Fields of papers citing papers by Adina Aviram

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Adina Aviram. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Adina Aviram. The network helps show where Adina Aviram may publish in the future.

Co-authorship network of co-authors of Adina Aviram

This figure shows the co-authorship network connecting the top 25 collaborators of Adina Aviram. A scholar is included among the top collaborators of Adina Aviram based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Adina Aviram. Adina Aviram is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Rozovski, Uri, Arie Apel, Adina Aviram, et al.. (2019). Midostaurin in Combination with Intensive Chemotherapy is Safe and Associated with Improved Remission Rates and Higher Transplantation Rates in First Remission-A Multi-Center Historical Control Study. Clinical Lymphoma Myeloma & Leukemia. 19. S208–S209. 3 indexed citations
3.
4.
Shepshelovich, Daniel, Alina Klein, Eli Muchtar, et al.. (2015). Acute promyelocytic leukemia with isochromosome 17q and cryptic PML-RARA successfully treated with all-trans retinoic acid and arsenic trioxide. Cancer Genetics. 208(11). 575–579. 10 indexed citations
5.
Abir, Ronit, Adina Aviram, Meora Feinmesser, et al.. (2013). Ovarian minimal residual disease in chronic myeloid leukaemia. Reproductive BioMedicine Online. 28(2). 255–260. 29 indexed citations
6.
7.
Sapoznikov, Boris, Pia Raanani, Adina Aviram, et al.. (2007). Follicular Lymphoma with Extensive Gastrointestinal Tract Involvement: Follow-up by Capsule Endoscopy. Digestive Diseases and Sciences. 52(4). 1031–1035. 5 indexed citations
8.
Hodak, Emmilia, et al.. (2006). CD4/CD8 double-negative epidermotropic cutaneous T-cell lymphoma: An immunohistochemical variant of mycosis fungoides. Journal of the American Academy of Dermatology. 55(2). 276–284. 78 indexed citations
9.
Hodak, Emmilia, et al.. (2004). Ichthyosiform mycosis fungoides: An atypical variant of cutaneous T-cell lymphoma. Journal of the American Academy of Dermatology. 50(3). 368–374. 24 indexed citations
10.
Aviram, Adina, et al.. (2003). Detection of methylated ABL1 promoter in philadelphia-negative myeloproliferative disorders. Blood Cells Molecules and Diseases. 30(1). 100–106. 9 indexed citations
11.
Zimra, Yael, et al.. (2000). Uptake of pivaloyloxymethyl butyrate into leukemic cells and its intracellular esterase-catalyzed hydrolysis. Journal of Cancer Research and Clinical Oncology. 126(12). 693–698. 18 indexed citations
12.
Aviram, Adina, Ada Rephaeli, Mati Shaklai, et al.. (1997). Effect of the cytostatic butyric acid pro-drug, pivaloyloxymethyl butyrate, on the tumorigenicity of cancer cells. Journal of Cancer Research and Clinical Oncology. 123(5). 267–271. 17 indexed citations
13.
Blickstein, Dorit, Adina Aviram, Jacob Luboshitz, et al.. (1997). BCR-ABL Transcripts in Bone Marrow Aspirates of Philadelphia-Negative Essential Thrombocythemia Patients: Clinical Presentation. Blood. 90(7). 2768–2771. 2 indexed citations
14.
Aviram, Adina, Ada Rephaeli, Mati Shaklai, et al.. (1997). Effect of the cytostatic butyric acid pro-drug, pivaloyloxymethyl butyrate, on the tumorigenicity of cancer cells. Journal of Cancer Research and Clinical Oncology. 123(5). 267–271. 2 indexed citations
15.
Blickstein, Dorit, Adina Aviram, Jacob Luboshitz, et al.. (1997). BCR-ABL Transcripts in Bone Marrow Aspirates of Philadelphia-Negative Essential Thrombocythemia Patients: Clinical Presentation. Blood. 90(7). 2768–2771. 31 indexed citations
16.
Aviram, Adina, et al.. (1994). Comparison between the effect of butyric acid and its prodrug pivaloyloxymethylbutyrate on histones hyperacetylation in an HL‐60 leukemic cell line. International Journal of Cancer. 56(6). 906–909. 46 indexed citations
17.
Nudelman, Abraham, et al.. (1992). Novel anticancer prodrugs of butyric acid. 2. Journal of Medicinal Chemistry. 35(4). 687–694. 85 indexed citations
18.
Rephaeli, Ada, et al.. (1988). Differentiation‐associated changes of cation‐transport activities in myeloid leukemic cell lines. FEBS Letters. 236(2). 401–405. 6 indexed citations
19.
Aviram, Adina, et al.. (1987). Fluoride-mediated activation of guinea pig neutrophils. Biochimica et Biophysica Acta (BBA) - Molecular Cell Research. 931(3). 262–266. 16 indexed citations
20.
Aviram, Adina & Irit Aviram. (1983). Activation of the respiratory burst of guinea pig neutrophils by dicyclohexylcarbodiimide. FEBS Letters. 155(2). 205–208. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by R P Warrell Breakdown of academic impact, for papers by Denise Levitan Breakdown of academic impact, for papers by Sara Morrow Breakdown of academic impact, for papers by Zhifang Zhai Breakdown of academic impact, for papers by C. Norman Coleman Breakdown of academic impact, for papers by Scott J. Ragg Breakdown of academic impact, for papers by Chaitanya Iragavarapu Breakdown of academic impact, for papers by Inês Mota Breakdown of academic impact, for papers by Shihong Shao Breakdown of academic impact, for papers by Renee Neades
Rankless by CCL
2026